ANGUS Chemical Company
John C. Sills is an accomplished executive with extensive experience in financial and operational leadership across various industries. Currently serving as COO/CFO/CAO at ANGUS Chemical Company since July 2017, Sills has been instrumental in guiding the international manufacturer of specialty chemical products owned by Golden Gate Capital. Prior roles include Chief Financial Officer at Phillips-Medisize, Inc. during its sale to Molex Industries, and Chief Financial Officer & Chief Administrative Officer at Unisource Worldwide, Inc., a major distributor with $4.1 billion in revenues. Additionally, Sills has a history of consulting for Bain Capital, leading Medical Specialties Distributors, and holding CFO roles at Robertson-Ceco Corporation and PwC. Educational credentials include a Master's in Business Administration from Northeastern University and a Bachelor's in Accounting & Finance from Lehigh University.
This person is not in any offices
ANGUS Chemical Company
ANGUS is a global specialty and fine chemical company dedicated to the development of novel chemistries that deliver enhanced product and process performance across a wide range of applications in pharmaceuticals, biotechnology, paints and coatings, agriculture, personal care, metalworking fluids, electronics and other industrial markets. Thecompany innovates through its unique nitroalkane chemistries, including its flagship AMP™ (aminomethyl propanol) multifunctional additives and TRIS AMINO™ tromethamine, which are produced at fully integrated, ISO 9001-certified manufacturing facilities in Sterlington, Louisiana, USA, and Ibbenbüren, Germany. ANGUS serves its global customers through six regional Customer Applications Centers located in Chicago, Illinois; Paris, France; São Paulo, Brazil; Singapore; Shanghai, China; and Mumbai, India.